CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE

07-8-2021 Press Release

U.S. House Oversight & Reform Committee Report Shines Light on Branded Drugmakers’ Profiteering Practices, Debunks Innovation Rhetoric For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to a new report from the U.S. House Committee on Oversight and Reform examining […]

CSRxP: Big Pharma Flaunts Disregard for Rx Affordability With Third Major Round of Pandemic Price Hikes

07-1-2021 Press Release

Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to a fresh round of price hikes from Big Pharma as the nation tries to recover from […]

ICYMI: BIG PHARMA USES INFLUENCE OVER PATIENT GROUPS & ASTROTURF TACTICS TO UNDERMINE RX SOLUTIONS

06-30-2021 Press Release

New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you missed it, Patients for Affordable Drugs (P4AD) released a new report Tuesday examining the financial levers and tactics used by Big Pharma to influence patient advocacy groups and a network of AstroTurf organizations to undermine support for solutions to lower drug prices […]

CSRXP APPLAUDS U.S. HOUSE PROBE INTO BIOGEN PRICING OF ADUHELM

06-25-2021 Press Release

Pallone and Maloney Announce Joint Investigation into Massive Price Tag on Unproven Alzheimer’s Treatment as Outrage Builds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on the announcement of a joint investigation into the pricing of unproven Biogen Alzheimer’s treatment Aduhelm by Representative […]

CSRXP: FDA APPROVAL AND SUBSEQUENT BIOGEN PRICING OF ADUCANUMAB DEMAND RETROSPECTION, REFORM

06-11-2021 Press Release

Troubling for Public Health Institution to Depart from Established Norms to Support Drug of Questionable Efficacy with Unjustifiable Price Tag For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reflecting on the recent U.S. Food and Drug Administration (FDA) approval of Alzheimer’s treatment […]

CSRXP AD BLITZ: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE NOW

06-1-2021 Press Release

Campaign Calls for Promises Made to the American People to Lower Prescription Drug Prices to Become Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched new television and digital advertising Tuesday encouraging policymakers to hold brand name drug companies accountable. The ad blitz, […]

CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET

05-28-2021 Press Release

Time for the Administration and Congress to Convert Promises Made Into Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on the release of President Biden’s Fiscal Year 2022 budget. “CSRxP commends President Biden for renewing his commitment to lowering prescription […]

CSRXP APPLAUDS PRESIDENT BIDEN’S CALL FOR BIPARTISAN SOLUTIONS TO LOWER DRUG PRICES

04-29-2021 Press Release

Administration and Congress Must Work Together To Pass Solutions to Hold Big Pharma Accountable and Deliver Relief for American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday in reaction to President Biden’s comments calling for Congress to pass solutions to lower […]

CSRXP: TIME FOR POLICYMAKERS TO DELIVER ON AMERICANS’ CALL TO LOWER OUT-OF-CONTROL DRUG PRICES

04-28-2021 Press Release

Holding Big Pharma Accountable Remains Top Priority for American Voters For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of President Biden’s introduction of the “American Families Plan” in an address to Congress. “We thank the President for correctly recognizing the importance […]

CSRXP: HR3 REINTRODUCTION ADDS TO MOMENTUM FOR D.C. TO LOWER DRUG PRICES, HOLD BIG PHARMA ACCOUNTABLE

04-22-2021 Press Release

Congress and the Administration Must Act on Solutions that Have Won Bipartisan Support to Deliver Relief for American Patients and Consumers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.